History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment
Authors
Keywords
-
Journal
HEADACHE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-22
DOI
10.1111/head.13379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sustained reductions in migraine days, moderate-to-severe headache days and days with acute medication use for HFEM and CM patients taking fremanezumab: Post-hoc analyses from phase 2 trials
- (2018) Rashmi B Halker Singh et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Salmon calcitonin ameliorates migraine pain through modulation of CGRP release and dural mast cell degranulation in rats
- (2018) Erkan Kilinc et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
- (2018) David W. Dodick et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Neurogenic inflammation and its role in migraine
- (2018) Roshni Ramachandran Seminars in Immunopathology
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- Erenumab (AMG 334) in episodic migraine
- (2017) Messoud Ashina et al. NEUROLOGY
- Fremanezumab for the Preventive Treatment of Chronic Migraine
- (2017) Stephen D. Silberstein et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
- (2017) Thuy Vu et al. PHARMACEUTICAL RESEARCH
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the CGRP Binding Monoclonal Antibody LY2951742 (Galcanezumab) in Healthy Volunteers
- (2017) David Monteith et al. Frontiers in Pharmacology
- Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors’ responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
- (2016) XiChun Zhang et al. CEPHALALGIA
- A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine
- (2016) Tiffini Voss et al. CEPHALALGIA
- Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Hong Sun et al. LANCET NEUROLOGY
- TEV-48125 for the preventive treatment of chronic migraine
- (2016) Marcelo E. Bigal et al. NEUROLOGY
- Wiping Out CGRP: Potential Cardiovascular Risks
- (2016) Antoinette MaassenVanDenBrink et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for prevention of headache in women with perimenstrual migraine
- (2015) Tony W Ho et al. CEPHALALGIA
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Aglycosylated full-length IgG antibodies: steps toward next-generation immunotherapeutics
- (2014) Man-Seok Ju et al. CURRENT OPINION IN BIOTECHNOLOGY
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
- (2014) T. W. Ho et al. NEUROLOGY
- BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial
- (2013) Ronald Marcus et al. CEPHALALGIA
- Insights into the structure of class B GPCRs
- (2013) Kaspar Hollenstein et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
- (2012) B R Chaitman et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease
- (2012) Tony W. Ho et al. HEADACHE
- CGRP and NO in the Trigeminal System: Mechanisms and Role in Headache Generation
- (2012) Karl Messlinger et al. HEADACHE
- Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
- (2011) David J Hewitt et al. CEPHALALGIA
- Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study
- (2011) Martin O. Behm et al. HEADACHE
- CGRP: Sensory neuropeptide with multiple neurologic implications
- (2011) E. E. Benarroch NEUROLOGY
- BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
- (2010) Hans-Christoph Diener et al. CEPHALALGIA
- Excellent Tolerability But Relatively Low Initial Clinical Efficacy of Telcagepant in Migraine
- (2010) Peer Tfelt-Hansen HEADACHE
- Randomized, controlled trial of telcagepant for the acute treatment of migraine
- (2009) K. M. Connor et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now